Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

With employers increasingly demanding job-ready graduates and clearer pathways from classroom to career, SUNY Polytechnic ...

Aviva Bio is advancing AVA-291 (d3-T) as a differentiated testosterone in a broad development program addressing multiple ...

Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...

Union Budget 2026 boosts education and skills with increased funding, university townships, and initiatives for employment ...

Deal activity, strategic funding and exploration momentum drove strong moves across small cap resources stocks on Friday. ...

Copper-gold excitement at Cannindah, bonanza-grade hits from Redcastle and Sunshine, plus a major scandium milestone at Mount Ridley highlight another ... Read More The post Resources Top 5: ...

Lehigh Carbon Community College is poised to become the hub of pharmaceutical workforce development in Pennsylvania. Following an announcement by Gov. Josh Shapiro at the Da Vinci Science Center, ...

Altimmune, Inc. closed a $75 million direct offering to fund Phase 3 pemvidutide trials for MASH. Learn more about ALT stock ...

Carbon markets allow countries, companies and communities to generate revenue by reducing emissions or increasing carbon ...

Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...

Gastrointestinal (GI) cancers, such as colorectal, gastric, and pancreatic cancers, are among the most prevalent and deadly worldwide. Despite advances in treatment, these cancers often remain ...